Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV). Nearly 300 million people worldwide live with this virus, which resulted in an estimated 820,000 preventable deaths in 2019. In 2016, WHO outlined a goal to end viral hepatitis as a public health problem by 2030. In a recent review, researchers systematically collected data to estimate the levels of HBV infection in Nigeria. This information will be critical for meeting global and national elimination goals. They found a prevalence of 9.5% – which is nearly 20,083,000 Nigerians. That is a high percentage. Infection rates differed by geographical area. The results point to the size of the potential liver disease crisis in Nigeria and where to focus prevention and care efforts with limited resources. The prevalence rate of 9.5% that emerged from our analysis means that Nigeria meets the WHO’s criteria for high endemicity.SOURCE: THE CONVERSATION
More Stories
Economic Perks of Growing Cycling Culture in North Africa
The Bank of Uganda Lowers Limits on the Value of Cheque Payments to Promote e-payments
Four Industrial Policy Regimes that have Shaped Africa
Ex Standard Bank Leader Cleared in Mozambique Price Fixing
Zanzibar and Pemba are about to Become a Test Site for a Mobile Internet Network
East Africa’s Mineral Deposits at the Centre of Future-facing Commodities
A Scramble for Controlling Interest in Nigeria’s Oldest Bank
Top Risks Facing South Africa
New Scheme to Save Zimbabwe’s Botched Land Reform
The First Floating LNG Facility is Deployed in the Deep Waters of the African Continent
The EU Lifts Air Travel Bans on Southern African States
Senegal’s Illustrious Portfolio of Architecture